Navigation Links
Neurobiological Technologies, Inc. and Buck Institute Partner to Develop Novel Treatment for Alzheimer's Disease
Date:3/3/2008

/www.buckinstitute.org.

About Neurobiological Technologies

Neurobiological Technologies, Inc, (Nasdaq: NTII) is a biopharmaceutical company focused on developing novel, first-in-class agents for central nervous system conditions and other serious unmet medical needs. The Company's most advanced product candidate in phase 3 clinical testing is Viprinex(TM) (ancrod), a novel agent with multiple mechanisms that is specifically designed to expand the treatment window for treating acute ischemic stroke, one of the most prevalent, debilitating and costly diseases in the world for which there are few acceptable treatment options. Its pipeline includes other drug candidates in early-stage development, including a first-of-its-kind drug for the treatment of Alzheimer's disease.

Forward-Looking Statements

Except for the historical information contained herein, the matters discussed in this press release are forward-looking statements that involve risks and uncertainties, including risks relating to the acquisition of new product candidates and our levels of future expenditures and capital resources, as well as other risks detailed from time to time in our Annual Report of Form 10-K and other filings with the Securities and Exchange Commission. Actual results may differ materially from those projected. These forward-looking statements represent our judgment as of the date of the release. We undertake no obligation to update these forward-looking statements.


'/>"/>
SOURCE Neurobiological Technologies, Inc.; Buck Institute for AgeResearch
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Emisphere Technologies, Inc. Announces 2007 Third Quarter Financial Results
2. Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure
3. Rockwell Medical Technologies, Inc. Begins Dosing Patients for SFP Phase IIb Clinical Study
4. Rockwell Medical Technologies, Inc. Begins Patient Enrollment for its SFP Dose-Ranging Study
5. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
6. Divine Corporations Personal Lubricants Shown to Block Cancer-causing Viruses in a Study by the National Cancer Institute
7. Sarasotas Roskamp Institute Highlights Positive Japanese Data that Validates its Ongoing Alzheimers Disease Research
8. New Conflict of Interest Violations Revealed at California Stem Cell Institute
9. American Legion Anticipates Institute of Medicine Report on Gulf War Veterans
10. SAIC Awarded Malaria Vaccine Production Support Contract Extension by the National Institute of Allergy and Infectious Diseases
11. American Meat Institute Calls WCRF Panel Recommendations on Meat Consumption Extreme and Unfounded
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... , January 15, 2014 Shire plc (LSE: ... the Office of Fair Trading (OFT) approval condition to the announced ... (NASDAQ: VPHM).   As a result of the waiver, ... expects to complete the tender offer on January 24, 2014 following ...
(Date:1/15/2014)... , Jan. 15, 2014  In an unprecedented effort to curb the ... ambulances and other transport vehicles, an advanced and portable UV germicidal ... for the first time. In order to prevent ... deadly pathogens, West Palm Beach Fire Rescue ...
(Date:1/15/2014)... , Jan. 15, 2014 The Cadence Fitness ... Fitness Center by the Medical Fitness Association, a non-profit ... achieve their full potential. The Cadence Fitness & Health ... western suburbs and second in the Chicagoland area. ...
Breaking Medicine Technology:Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 2Shire Waives OFT Condition Relating to the Acquisition of ViroPharma Inc. 3Superbugs No Longer Ride In Rescue Vehicles 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 2Cadence Fitness & Health Center Certified as Medical Fitness Facility 3
... An alarming study,that appeared in the March 1, ... American Cancer Society), reports that one-third of,women taking ... treatment tamoxifen citrate, discontinue therapy early.(1), According to ... issue that may negatively affect treatment efficacy.,While tamoxifen ...
... of one notorious,childhood disease, poliovirus, could be used ... neuroblastoma. In the March 15,issue of Cancer Research, ... -- or non-virulent -- form of poliovirus,is effective ... mice had been previously vaccinated against the virus. ...
Cached Medicine Technology:One-Third of Patients Discontinue Common Breast Cancer Therapy 2One-Third of Patients Discontinue Common Breast Cancer Therapy 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 2Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 3Researchers Use Poliovirus to Destroy Neuroblastoma Tumors in Mice 4
(Date:4/17/2014)... the most popular vaccine brands for children may not ... overlooking some cost factors when choosing vaccines, driving the ... according to a new study by University of Illinois ... be driven by numerous factors," says Sheldon H. Jacobson, ... computer science and of mathematics at the U. of ...
(Date:4/17/2014)... California, San Diego School of Medicine report that older ... recent major loss are more likely to be compassionate ... is published in this month,s issue of the ... behaviors are associated with better health and well-being as ... to improve the outcomes of individuals whose deficits in ...
(Date:4/17/2014)... MD, was recently invited to submit a review ... Microbiology , one of the world,s foremost scientific ... specialist, and chair of the Department of Pediatrics ... analyzed the epidemiology and microbiology of co-infections during ... as more recent 2009 novel H1N1 pandemic. ...
(Date:4/17/2014)... Doctors who treat patients with a severe ... face an agonizing treatment decision. , The drug ... help relieve shortness of breath. But some patients ... cause potentially fatal complications following transplantation. , "It,s ... medical director of Loyola University Medical Center,s LAM ...
(Date:4/17/2014)... 17, 2014-- Colic affects about one in five infants ... pediatric visits during the first several months after birth. ... was showing promise; however, the April 1, 2014 issue ... Valerie) reported on a study, "Probiotics and Infant Colic," ... reuteri for infant colic did not reduce ...
Breaking Medicine News(10 mins):Health News:Study recalculates costs of combination vaccines 2Health News:The ilk of human kindness 2Health News:Patients with rare lung disease face agonizing treatment dilemma 2Health News:Patients with rare lung disease face agonizing treatment dilemma 3Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2
... , , ORLANDO, Fla., ... new report today at its annual convention in Toronto acknowledging ... comes to dealing with conflicts between religious beliefs and same-sex ... conflict with their sexuality and faith, says this report acknowledges ...
... ... , ... Atlanta, GA (Vocus) August 5, 2009 -- CareFirst BlueCross BlueShield (CareFirst) today announced that ... in National Account Service Company LLC (NASCO), joining the Blue Cross and Blue Shield ...
... , , BOSTON, Aug. 5 ... management solutions, today reported unaudited financial results for the second quarter ended June ... ) , , Q2 Financial Highlights ... second quarter of 2009 was $23.5 million, compared to $13.6 million for the ...
... , , HARRISBURG, Pa., Aug. ... of Massage Therapy began drafting preliminary regulations that will protect ... Commonwealth Pedro A. Cortes. , , "By ... and training, we can provide the best and most up-to-date ...
... , , ST. PAUL, Minn., Aug. ... Extreme Makeover: Home Edition (EMHE) premieres its seventh season ... be among a select group as a Designated Charity for an ... Duluth/Superior area. The EMHE episode, air date to be announced at ...
... simply a marker for obesity is unclear , , WEDNESDAY, ... activates sex hormones throughout the body may also predict those ... study finds. , The protein, called sex hormone-binding globulin (SHBG), ... Researchers suspect it also plays a role in the development ...
Cached Medicine News:Health News:APA Releases Report on Sexuality Debate 2Health News:APA Releases Report on Sexuality Debate 3Health News:CareFirst Joins Partnership of Blues Plans as Owner of NASCO 2Health News:CareFirst Joins Partnership of Blues Plans as Owner of NASCO 3Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 2Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 3Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 4Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 5Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 6Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 7Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 8Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 9Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 10Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 11Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 12Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 13Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 14Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 15Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 16Health News:AMICAS Reports Financial Results for the Second Quarter Ended June 30, 2009 17Health News:State Regulation of Massage Therapy Will Improve Public Health, Safety 2Health News:State Regulation of Massage Therapy Will Improve Public Health, Safety 3Health News:Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity 2Health News:Memorial Blood Centers Joins Extreme Makeover: Home Edition As Designated Charity 3Health News:Sex Hormone Protein May Predict Type 2 Diabetes 2Health News:Sex Hormone Protein May Predict Type 2 Diabetes 3
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
Medicine Products: